PNOC001 trial results on everolimus for progressive/recurrent pLGGs and genomic biomarkers published in the Journal of Clinical Oncology

Haas-Kogan DA, Aboian MS, Minturn JE, Leary SES, Abdelbaki MS, Goldman S, Elster JD, Kraya A, Lueder MR, Ramakrishnan D, von Reppert M, Liu KX, Rokita JL, Resnick AC, Solomon DA, Phillips JJ, Prados M, Molinaro AM, Waszak SM#, Mueller S#. Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial. Journal of Clinical Oncology (2023). doi:10.1200/JCO.23.01838. #equal contribution as senior authors.

Simultaneous presentation at the 28th Annual SNO Meeting was recognised with a Poster Award.